That is not what the DEA means by a secure access.
They mean nobody (AS IN NOBODY) that isn't authorized can get to those substances. Cleaning would be under supervision.
But that was not the point. I was just saying that PPHM's CRO CSM, the more I research them, is that bad of a company. They are realy involved in their business and CEO Finken more the ones shows up in good quality publications.
This is one of them where by the way (for biopharm) it shows that Finken HIMSELF came from PRACS Institute Ltd, formerly Cetero. Other people do to such as Trista Radcliffe.
I was actually enforcing my case that the CSM "the company" certainly seems a decent business and if whatever happened their with PPHM clinical trial must have been driven by an individual. It also means PPHM has some decent changes to be made hole!
So the critics that ones were posted here that Peregrine made a bad choice and that being licensed by the FDA as CRO for these trials doesn't mean anything should not be taken for granted.
CSM is not just your average backyard garage operation, I actually start to have a good impression of them.
News 
Market Data 
Discover 
